REMS in SPL Webinar Original

November 4, 2016
SPL expert Gary Saner discusses the FDA's new initiative to receive Risk Evaluation and Mitigation Strategy (REMS) submissions in Structured Product Labeling format.
Previous Video
REMS in SPL Webinar
REMS in SPL Webinar

SPL expert Gary Saner discusses the FDA's new initiative to receive Risk Evaluation and Mitigation Strategy...

Next Video
FDA Drug Establishment Site Registration Webinar
FDA Drug Establishment Site Registration Webinar

SPL subject matter expert Jon Nolan gives an overview of the FDA's requirements for registering Drug Establ...